We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00842491
Recruitment Status : Completed
First Posted : February 12, 2009
Last Update Posted : May 19, 2015
Xiansheng Pharmaceutical Company
Information provided by (Responsible Party):
Shen Lin, Peking University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2010
  Study Completion Date : December 2010